If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

Share Price is delayed by 15 minutes
Get Live Data
0.021    0.00 (0.00%)
Bid:
0.02
Ask:
0.022
Spread: 0.002 (10.00%)
Market Cap: £4.35m
IRON Live PriceLast checked at - London Stock Exchange

Intraday Ironveld Share Chart

Board Appointment

2 Nov 2022 07:00

RNS Number : 9779E
Ironveld PLC
02 November 2022
 

Ironveld Plc

("Ironveld" or the "Company")

Board Appointment

Ironveld (AIM:IRON) is pleased to announce the appointment of Dr John Wardle as a Non-Executive Director of the Company, with immediate effect.

 

John, whose first degree was in Mining Engineering followed by a PhD in Microseismic Geotechnics, was most recently CEO of Amerisur Resources Plc, the AIM-listed Oil & Gas company, from 2007 to 2020 when it was acquired for approximately £242 million. Prior to this John held roles with BP, Britoil, Emerald Energy and Pebercan.

 

John is the 100% beneficial owner of Tracarta Limited, which holds 237,046,901 ordinary shares in Ironveld representing 8.19 per cent. of the Company's issued share capital.

 

John will also become a member of Ironveld's Audit and Remuneration Committees.

 

Commenting, Ironveld Chairman Giles Clarke, said

 

"I am delighted to welcome John to the Board at this critical and exciting time in Ironveld's development. As well as being a supportive shareholder in the Company, John and I worked together successfully for many years at Amerisur and I know that he brings an impressive range of skills and experience to support the Executive team as we make the transition into production."

 

Regulatory disclosures

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Dr John Wardle, aged 63:

Current Directorships

None

Directorships within the past 5 years:

Amerisur Resources plc

Ironveld confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Dr John Wardle.

 

For further information, please contact:

Ironveld plc

Martin Eales, Chief Executive Officer

c/o BlytheRay

020 7138 3204

 

 

finnCap (Nomad and Broker)

Christopher Raggett

Charlie Beeson

 

 

020 7220 0500

 

 

Turner Pope (Joint Broker)

Andy Thacker

James Pope

 

 

020 3657 0050

BlytheRay

Megan Ray

Tim Blythe

 

020 7138 3204

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKFFESNAFFA
Date   Source Headline
25th Jul 20179:07 amRNSHolding(s) in Company
24th Jul 20177:00 amRNSCompany Update
10th Jul 20171:29 pmRNSResult of General Meeting
21st Jun 20175:30 pmRNSPlacing, Potential Acquisition and Notice of GM
28th Apr 20177:00 amRNSGranting of Licenses
25th Apr 20172:28 pmRNSBlocklisting Return
11th Apr 20177:00 amRNSPlanned acquisition of smelting business
29th Mar 20177:00 amRNSInterim results for six months ended 31 Dec 2016
2nd Feb 201711:02 amRNSConversion of consultants fees into equity
26th Jan 20174:18 pmRNSTR-1: Notification of Major Interest in Shares
5th Jan 201712:05 pmRNSResult of AGM
21st Dec 201611:06 amRNSNotice of AGM
7th Dec 20167:00 amRNSFinal results for the year ended 30 June 2016
22nd Nov 20167:00 amRNSInvestor evening - 1 December 2016
14th Nov 201611:45 amRNSResult of General Meeting
1st Nov 20167:00 amRNSTotal Voting Rights and Blocklisting Return
26th Oct 20161:21 pmRNSPlacing to raise c.£1.8 million and Notice of GM
6th Oct 20167:00 amRNSProject Finance Facilities and Offtake
2nd Sep 20169:28 amRNSConversion of consultants fees into equity
7th Jun 20167:00 amRNSVanadium Slag Offtake Agreement Signed
20th May 20167:00 amRNSOfftake Agreement and Final Approvals
30th Mar 20167:00 amRNSInterim Results
23rd Mar 201611:06 amRNSHolding(s) in Company
28th Jan 20167:00 amRNSGrant of Share Options
27th Jan 20164:03 pmRNSConversion of Directors' fees into equity
18th Dec 201510:00 amRNSResult of AGM
18th Dec 20157:00 amRNSFinal Approvals and Company Update
23rd Nov 20157:00 amRNSFinal Results
23rd Oct 20157:00 amRNSBlocklisting Return
5th Oct 20157:00 amRNSFunding update & Senior Management Appointment
21st Aug 20153:03 pmRNSHolding(s) in Company
4th Aug 20157:00 amRNSConversion of consultants fees into equity
3rd Aug 20157:00 amRNSOperational Update
9th Jul 20157:00 amRNSConversion of Directors' fees into equity
7th Jul 20157:00 amRNSAppointment of Chief Financial Officer
29th Jun 201510:11 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSEnvironmental Impact Assessment approved
18th Jun 20157:00 amRNSPlacing and Project Development Update
23rd Apr 20155:30 pmRNSBlocklisting Return
30th Mar 20157:00 amRNSHalf Yearly Report
26th Mar 20157:00 amRNSMining Right Application submitted
19th Mar 20157:00 amRNSDirectorate Change
4th Mar 20157:00 amRNSConversion of consultants fees into equity
2nd Mar 20157:00 amRNSGranting of Mining Right
17th Feb 20157:00 amRNSCritical Infrastructure Programme Application
9th Jan 20155:16 pmRNSConversion of Directors' fees into equity
29th Dec 201411:01 amRNSResult of AGM
15th Dec 20147:00 amRNSHolding(s) in Company
11th Dec 20147:00 amRNSDirector/PDMR Shareholding
9th Dec 20148:46 amRNSDirector's Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.